QQ客服 官方微博 反馈留言

	Riccardin D-26, a synthesized macrocyclic bisbibenzyl compound, inhibits human hepatocellular carcinoma growth through induction of apoptosis in p53-dependent way
	Yue, Bin; Zhang, Yu-Sheng; Xu, Hui-Min; Zhao, Cui-Rong; Li, Yuan-Yuan; Qin, Yi-Zhuo; Wang, Rui-Qi; Sun, Di; Yuan, Yi; Lou, Hong-Xian 更多
刊名	CANCER LETTERS
	2013
卷号	328期号:1页码:104-113
关键词	Macrocyclic bisbibenzyls Synthesized Riccardin D Hepatocellular carcinoma Apoptosis p53-Dependent pathway
DOI	10.1016/j.canlet.2012.09.002
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5175275
专题	山东大学
作者单位	Shandong Univ, Sch Pharmaceut
推荐引用方式 GB/T 7714	Yue, Bin,Zhang, Yu-Sheng,Xu, Hui-Min,et al. Riccardin D-26, a synthesized macrocyclic bisbibenzyl compound, inhibits human hepatocellular carcinoma growth through induction of apoptosis in p53-dependent way[J]. CANCER LETTERS,2013,328(1):104-113.
APA	Yue, Bin.,Zhang, Yu-Sheng.,Xu, Hui-Min.,Zhao, Cui-Rong.,Li, Yuan-Yuan.,...&Lou, Hong-Xian 更多.(2013).Riccardin D-26, a synthesized macrocyclic bisbibenzyl compound, inhibits human hepatocellular carcinoma growth through induction of apoptosis in p53-dependent way.CANCER LETTERS,328(1),104-113.
MLA	Yue, Bin,et al."Riccardin D-26, a synthesized macrocyclic bisbibenzyl compound, inhibits human hepatocellular carcinoma growth through induction of apoptosis in p53-dependent way".CANCER LETTERS 328.1(2013):104-113.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。